Attenuation of acute xenograft rejection by short-term treatment with LF15-0195 and monoclonal antibody against CD45RB in a rat-to-mouse cardiac transplantation model

Transplantation

Volumn 75, Issue 9, 2003, Pages 1475-1481

  Wang, Hao ^a,b,c   Hosiawa, Karoline A ^b,c   Garcia, Bertha ^b   Shum, Jeffrey B ^c   Dutartre, Patrick ^d   Kelvin, David J ^b,c   Zhong, Robert ^a,b,c  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

^d Laboratoires Fournier SA   (France)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXYSPERGUALIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; IMMUNOSUPPRESSIVE AGENT; LF 150195; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ADOLESCENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; BLEEDING; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; FIBRIN DEPOSITION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; THROMBOSIS; XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY FORMATION; ANTIGENS, CD45; GRAFT REJECTION; GRAFT SURVIVAL; GUANIDINES; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, INBRED BALB C; MYOCARDIUM; RATS; RATS, INBRED LEW; TRANSPLANTATION, HETEROLOGOUS;

EID: 0038247839     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000057245.59998.95     Document Type: Article

References (30)

1. Platt JL, Lin SS, McGregor CGA. Acute vascular rejection. Xenotransplantation 1998; 5: 169.
2. Bach FH, Winkler H, Ferran C, et al. Delayed xenograft rejection. Immunol Today 1996; 17: 379.
3. Cotterell AH, Collins BH, Parker W, et al. The humoral immune response in humans following cross-perfusion of porcine organs. Transplantation 1995; 60: 861.
4. Lin SS, Weidner BC, Byrne GW, et al. The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J Clin Invest 1998; 101: 1745.
5. Dalmasso AP, Vercellotti GM, Fischel RJ, et al. Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. Am J Pathol 1992; 140: 1157.
6. Schaapherder AF, Daha MR, te Bulte MT, et al. Antibody-dependent cell-mediated cytotoxicity against porcine endothelium induced by a majority of human sera. Transplantation 1994; 57: 1376.
7. Zaidi A, Schmoeckel M, Bhatti F, et al. Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors. Transplantation 1998; 65: 1584.
8. Marchman W, Araneda D, DeMasi R, et al. Prolongation of xenograft survival after combination therapy with 15-deoxyspergualin and total-lymphoid irradiation in the hamster-to-rat cardiac xenograft model. Transplantation 1992; 53: 30.
9. Reichenspurner H, Human PA, Boehm DH, et al. Optimalization of immunosuppression after xenogeneic heart transplantation in primates. J Heart Transplant 1989; 8: 200.
10. Chiffoleau E, Dutartre P, Usual C, et al. Mechanisms of induction of allograft tolerance in rat by short-term treatment with LF15-0195. Am J Transplant 2001; 1(suppl 1): 167.
11. Zhou D, O'Brien C, Garcia B, et al. LF15-0195, a novel immunosuppressive agent prevents rejection and induces tolerance in a mouse cardiac allograft model. Am J Transplant 2001; 1(suppl 1): 437.
12. Yang H, Kanai N, Garcia B, et al. LF 15-0195, an analogue of 15-deoxyspergualin (DSG), monotherapy significantly prolonged renal allograft survival in monkeys. Am J Transplant 2002; 2(suppl 3): 361.
13. Sebille F, Guillet M, Brouard S, et al. T-cell-mediated rejection of vascularized xenografts in the absence of induced anti-donor antibody response. Am J Transplant 2001; 1: 21.
14. Zhong RZ, Lazarovits AI. Monoclonal antibody against CD45RB for the therapy of rejection and autoimmune diseases. J Mol Med 1998; 76: 572.
15. Luke PP, O'Brien CA, Jevnikar AM, et al. Anti-CD45RB monoclonal antibody-mediated transplantation tolerance. Curr Mol Med 2001; 1: 533.
16. Lazarovits AI, Poppema S, White MJ, et al. Inhibition of alloreactivity in vitro by monoclonal antibodies directed against restricted isoforms of the leukocyte-common antigen (CD45). Transplantation 1992; 54: 724.
17. Basadonna GP, Auersvald L, Khuong CQ, et al. Antibody-mediated targeting of CD45 isoforms: a novel immunotherapeutic strategy. Proc Natl Acad Sci USA 1998; 95: 3821.
18. Lazarovits AI, Poppema S, Zhang Z, et al. Prevention and reversal of renal allograft rejection by antibody against CD45RB. Nature 1996; 380: 717.
19. Min W, Zhou D, Visser L, et al. Synergistic effect of anti-CD45RB mAb and LF15-0195 on tolerance is due to interaction of regulatory T cells and tolerogenic dendritic cells. Am J Transplant 2002; 2(suppl 3): 389.
20. Corry RJ, Winn HJ, Russell PS. Primary vascularized allograft of hearts in mice. Transplantation 1973; 16: 343.
21. Wang H, DeVries ME, Deng S, et al. The axis of interleukin 12 and gamma interferon regulates acute vascular xenogeneic rejection. Nat Med 2000; 6: 549.
22. Wang H, Rollins S, Gao Z, et al. Complement inhibition with an anti-C5 monoclonal antibody prevents hyperacute rejection in a xenograft heart transplantation model. Transplantation 1999; 68: 1643.
23. Lebreton L, Annat J, Derrepas P, et al. Structure-immunosuppressive activity relationships of new analogues of 15-deoxyspergualin. 1. Structural modifications of the hydroxyglycine moiety. J Med Chem 1999; 42: 277.
24. Gao Z, Zhong R, Jiang J, et al. Adoptively transferable tolerance induced by CD45RB monoclonal antibody. J Am Soc Nephrol 1999; 10: 374.
25. Zhang Z, Lazarovits A, Gao Z, et al. Prolongation of xenograft survival using monoclonal antibody CD45RB and cyclophosphamide in rat-tomouse kidney and heart transplant models. Transplantation 2000; 69: 1137.
26. Tepper MA, Nadler SG, Esselstyn JM, et al. Deoxyspergualin inhibits kappa light chain expression in 70Z/3 pre-B cells by blocking lipopolysaccharide-induced NF-kappa B activation. J Immunol 1995; 155: 2427.
27. Thanos D, Maniatis T. NF-kappa B: a lesson in family values. Cell 1995; 80: 529.
28. Van den Bogaerde, White DJ. Xenogeneic transplantation. Br Med Bull 1997; 53: 904.
29. Fryer JP, Leventhal JR, Dalmasso AP, et al. Cellular rejection in discordant xenografts when hyperacute rejection is prevented: analysis using adoptive and passive transfer. Transpl Immunol 1994; 2: 87.
30. Lin Y, Vandeputte M, Waer M. Natural killer cell- and macrophagemediated rejection ofconcordant xenograft in the absence of T and B cell responses. J Immunol 1997; 158: 5658.